Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Fallara

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
Radiation Oncology (London, England)|October 18, 2020
A non-invasive ultrasound imaging method to measure acute radiation-induced bladder wall thickening in ratsAntonello E Spinelli, Andrea Bresolin, Stefania Zuppone, et al.
Urologic Oncology|January 9, 2025
Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211Giuseppe Fallara, Federico Belladelli, Daniele Robesti, et al.
Advances in Therapy|March 19, 2025
A Noninterventional, Cross-Sectional Study to Assess Patient Prostate Cancer Treatment Preferences and Experiences in EuropeEmmanuelle Kaltenbach, Ana Maria Rodriguez-Leboeuf, Patrick Cabri, et al.
Cancers|March 28, 2026
Nerve-Sparing in High-Risk Prostate Cancer: Advantages and Pitfalls of Current Strategies and TechnologiesDaniele Robesti, Pierluigi Russo, Giuseppe Fallara, et al.
Cancer Treatment Reviews|August 8, 2022
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysisGiuseppe Fallara, Daniele Robesti, Luigi Nocera, et al.
Andrology|June 21, 2022
The impact of different WHO reference criteria for semen analysis in clinical practice: Who will benefit from the new 2021 thresholds for normal semen parameters?Luca Boeri, Giuseppe Fallara, Edoardo Pozzi, et al.
European Urology Focus|August 2, 2025
Shaping the Future of Personalized Therapy in Bladder Cancer Using Artificial IntelligenceMartina Maggi, Francesco Chierigo, Giuseppe Fallara, et al.
European Urology Focus|June 25, 2020
Ten-year Follow-up Results After Holmium Laser Enucleation of the ProstateGiuseppe Fallara, Paolo Capogrosso, Nicolò Schifano, et al.
BJU International|July 9, 2023
The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy: analysis of individual patient data from IMvigor210 and IMvigor211 trialsDaniele Robesti, Luigi Nocera, Federico Belladelli, et al.
Andrology|June 1, 2023
Hyperestrogenism is associated with sexual function impairment in men-findings from a cross-sectional, real-life studyFederico Belladelli, Luca Boeri, Giuseppe Fallara, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
Radiation Oncology (London, England)|October 18, 2020
A non-invasive ultrasound imaging method to measure acute radiation-induced bladder wall thickening in ratsAntonello E Spinelli, Andrea Bresolin, Stefania Zuppone, et al.
Urologic Oncology|January 9, 2025
Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211Giuseppe Fallara, Federico Belladelli, Daniele Robesti, et al.
Advances in Therapy|March 19, 2025
A Noninterventional, Cross-Sectional Study to Assess Patient Prostate Cancer Treatment Preferences and Experiences in EuropeEmmanuelle Kaltenbach, Ana Maria Rodriguez-Leboeuf, Patrick Cabri, et al.
Cancers|March 28, 2026
Nerve-Sparing in High-Risk Prostate Cancer: Advantages and Pitfalls of Current Strategies and TechnologiesDaniele Robesti, Pierluigi Russo, Giuseppe Fallara, et al.
Cancer Treatment Reviews|August 8, 2022
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysisGiuseppe Fallara, Daniele Robesti, Luigi Nocera, et al.
Andrology|June 21, 2022
The impact of different WHO reference criteria for semen analysis in clinical practice: Who will benefit from the new 2021 thresholds for normal semen parameters?Luca Boeri, Giuseppe Fallara, Edoardo Pozzi, et al.
European Urology Focus|August 2, 2025
Shaping the Future of Personalized Therapy in Bladder Cancer Using Artificial IntelligenceMartina Maggi, Francesco Chierigo, Giuseppe Fallara, et al.
European Urology Focus|June 25, 2020
Ten-year Follow-up Results After Holmium Laser Enucleation of the ProstateGiuseppe Fallara, Paolo Capogrosso, Nicolò Schifano, et al.
BJU International|July 9, 2023
The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy: analysis of individual patient data from IMvigor210 and IMvigor211 trialsDaniele Robesti, Luigi Nocera, Federico Belladelli, et al.
Andrology|June 1, 2023
Hyperestrogenism is associated with sexual function impairment in men-findings from a cross-sectional, real-life studyFederico Belladelli, Luca Boeri, Giuseppe Fallara, et al.
Pageof 15